Paid Clinical Trials in San Antonio, TX

As of June 2026, 1,053 paid clinical trials are recruiting in San Antonio, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,053 clinical trials

↓ Download CSV

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

for Lung Cancer (Diagnosis)

7 locations incl. Palo Alto

Sponsor: bioAffinity Technologies Inc.

Sex: All·Age: 50 - 80

Code: NCT07168993·Recruiting

Apply to this trial

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

for Non-Diabetic

2 locations incl. San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07212868·Phase 1·Recruiting

Apply to this trial

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

for Breast Cancer

8 locations incl. Los Angeles

Sponsor: Boundless Bio, Inc.

Sex: All·Age: 18+

Code: NCT07408089·Phase 1·Recruiting

Apply to this trial

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for Esophageal Squamous Cell Carcinoma

5 locations incl. Austin

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18+

Code: NCT07503808·Phase 1·Recruiting

Apply to this trial

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for Locally Advanced Adrenal Cortical Carcinoma

Drug: Cabozantinib

69 locations incl. La Jolla

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 12+

Code: NCT06900595·Phase 2·Recruiting

Apply to this trial

AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

for Corneal Edema

12 locations incl. Mesa

Sponsor: Aurion Biotech

Sex: All·Age: 18+

Code: NCT07368959·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

for Healthy Volunteers

1 location in San Antonio

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07422298·Phase 1·Recruiting

Apply to this trial

TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study

for Hemorrhage, Surgical

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 2 - 17

Code: NCT06580509·EARLY_Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for Multiple Myeloma

3 locations incl. West Hollywood

Sponsor: C4 Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284758·Phase 2·Recruiting

Apply to this trial

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced / Metastatic Solid Tumors

9 locations incl. Denver

Sponsor: Crescent Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07335497·Phase 1, Phase 2·Recruiting

Apply to this trial

Validation and Usability Study of the SleepView+ Home Sleep Testing System for the Evaluation of Moderate to Severe Obstructive Sleep Apnea.

for Obstructive Sleep Apnea

4 locations incl. Redwood City

Sponsor: Beacon Biosignals

Sex: All·Age: 12+·Accepts healthy volunteers

Code: NCT07476313·Enrolling By Invitation

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

for Advanced Solid Tumors

4 locations incl. New Haven

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07360314·Phase 1·Recruiting

Apply to this trial

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

for MASH - Metabolic Dysfunction-Associated Steatohepatitis

31 locations incl. Chandler

Sponsor: Rivus Pharmaceuticals, Inc.

Sex: All·Age: 30+

Code: NCT07491458·Phase 2·Recruiting

Apply to this trial

Quitxt Mobile Text Messaging Cessation Research Study

for Smoking Cessation

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18 - 29·Accepts healthy volunteers

Code: NCT05958667·Recruiting

Apply to this trial

ROME GS System Study

for Diabetes

4 locations incl. Escondido

Sponsor: Senseonics, Inc.

Sex: All·Age: 18+

Code: NCT07518004·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

for Sleep Apnea, Obstructive

Drug: Eloralintide

23 locations incl. Cullman

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07369011·Phase 3·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for Overweight

Drug: Eloralintide

54 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07392190·Phase 3·Recruiting

Apply to this trial

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

for Age Related Cataracts

21 locations incl. Scottsdale

Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

Sex: All·Age: 50+

Code: NCT07395986·Phase 2·Enrolling By Invitation

A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

for Hepatic Insufficiency

Drug: Eloralintide

2 locations incl. Orlando

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT07401862·Phase 1·Recruiting

Apply to this trial

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for Osteoarthritis

Drug: Eloralintide

37 locations incl. Mobile

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07353931·Phase 3·Recruiting

Apply to this trial

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

for Diabetic Macular Edema

Drug: Aflibercept

48 locations incl. Gilbert

Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07449923·Phase 3·Recruiting

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

for Advanced Solid Tumor

6 locations incl. Boston

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213830·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for Obesity

Drug: Eloralintide

41 locations incl. Tuscaloosa

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07321886·Phase 3·Recruiting

Apply to this trial

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for Type II Diabetes Mellitus

31 locations incl. Birmingham

Sponsor: Corxel Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT07340320·Phase 2·Recruiting

Apply to this trial

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for TP53 Y220C Mutation

Drug: rezatapopt

5 locations incl. Denver

Sponsor: PMV Pharmaceuticals, Inc

Sex: All·Age: 18+

Code: NCT07372625·Phase 1·Recruiting

Apply to this trial

DPTX3186 in Wnt Pathway Activated Solid Tumors

for Solid Tumors

2 locations incl. San Antonio

Sponsor: Dewpoint Therapeutics

Sex: All·Age: 18+

Code: NCT07312903·Phase 1·Recruiting

Apply to this trial

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

for Advanced Solid Tumors

Drug: Ivonescimab

5 locations incl. Norwich

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07397338·Phase 1, Phase 2·Recruiting

Apply to this trial

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for Adenocarcinoma

10 locations incl. Scottsdale

Sponsor: Corcept Therapeutics

Sex: All·Age: 18+

Code: NCT07259317·Phase 2·Recruiting

Apply to this trial

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

for Solid Tumor

1 location in San Antonio

Sponsor: Lei Zheng

Sex: All·Age: 18+

Code: NCT07086768·Phase 1·Recruiting

Apply to this trial

A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

for Graves' Disease

Drug: IMVT-1402

89 locations incl. Phoenix

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18+

Code: NCT07286006·Phase 2·Enrolling By Invitation

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Duvakitug

14 locations incl. Colorado Springs

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07184944·Phase 3·Recruiting

Apply to this trial

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

for Dermatitis, Atopic

12 locations incl. Houston

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07230860·Phase 2·Recruiting

Apply to this trial

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis

for Lupus Nephritis

11 locations incl. Gilbert

Sponsor: Autolus Limited

Sex: All·Age: 12 - 65

Code: NCT07053800·Phase 2·Recruiting

Apply to this trial

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for Ulcerative Colitis

Drug: Duvakitug

21 locations incl. Coronado

Sponsor: Sanofi

Sex: All·Age: 16 - 80

Code: NCT07185009·Phase 3·Recruiting

Apply to this trial

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

for Neoplasms

Drug: Nivolumab

4 locations incl. Los Angeles

Sponsor: Corcept Therapeutics

Sex: All·Age: 18+

Code: NCT07276373·Phase 1, Phase 2·Recruiting

Apply to this trial

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

for Renal Cell Carcinoma

Drug: BMS-986506

5 locations incl. Boston

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07195682·Phase 1·Recruiting

Apply to this trial

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for Chronic Inducible Urticaria

26 locations incl. Birmingham

Sponsor: Celldex Therapeutics

Sex: All·Age: 18+

Code: NCT07266402·Phase 3·Recruiting

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

for Colorectal Cancer

8 locations incl. Duarte

Sponsor: Cartography Biosciences

Sex: All·Age: 18+

Code: NCT07321106·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

for Breast Cancer

Drug: Giredestrant

2 locations incl. Grand Rapids

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT07214662·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

for CKD

19 locations incl. Chula Vista

Sponsor: Renibus Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07355062·Phase 3·Recruiting

Apply to this trial